Ownership Submission
FORM 3
 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Expires: January 31, 2005
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
  Gordon Joseph F
 2. Date of Event Requiring Statement (Month/Day/Year)
08/02/2018		 3. Issuer Name and Ticker or Trading Symbol
Bausch Health Companies Inc. [BHC]
(Last)
(First)
(Middle)
400 SOMERSET CORPORATE BLVD.		 4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
__X__ Officer (give title below) _____ Other (specify below)
President Bausch & Lomb/Int'l
 5. If Amendment, Date Original Filed(Month/Day/Year)
(Street)

BRIDGEWATER, NJ 08807		 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)		 2. Amount of Securities Beneficially Owned
(Instr. 4)		 3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)		 4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Shares, No Par Value 40,394 (1)
D
 

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. SEC 1473 (7-02)
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 4)		 2. Date Exercisable and Expiration Date
(Month/Day/Year)		 3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)		 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)		 6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Non-qualified Stock Options (right To Purchase)   (2) 08/09/2023 Common Shares, No Par Value 15,075 $ 101.68 D  
Non-qualified Stock Options (right To Purchase)   (3) 06/09/2026 Common Shares, No Par Value 15,582 $ 23.92 D  
Non-qualified Stock Options (right To Purchase)   (3) 03/01/2027 Common Shares, No Par Value 40,231 $ 14.38 D  
Non-qualified Stock Options (right To Purchase)   (3) 03/07/2028 Common Shares, No Par Value 40,568 $ 15.32 D  
Restrcited Share Units   (4) 01/06/2020 Common Stock, No Par Value 5,461 $ (4) D  
Restrcited Share Units   (5) 03/20/2021 Common Stock, No Par Value 4,546 $ (5) D  

Reporting Owners

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Gordon Joseph F
400 SOMERSET CORPORATE BLVD.
BRIDGEWATER, NJ 08807		       President Bausch & Lomb/Int'l  

Signatures

/s/ Kirsten O'Donnell, attorney-in-fact for Joseph F. Gordon 08/10/2018
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) Includes 26,581 restricted share units ("RSUs") which vest in equal installments on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in Common Shares, no par value ("Common Shares") of Bausch Health Companies Inc. ("Bausch Health").
(2) Vests in equal installments on each of the first four anniversaries of the date of grant.
(3) Vests in equal installments on each of the first three anniversaries of the date of grant.
(4) Represents a grant of performance-based RSUs. The target number of performance-based RSUs granted to the reporting person was 5,461 and the maximum number that can be distributed is 10,922. The performance-based RSUs shall vest and be distributed between 0-200% of target based on Bausch Health's Total Shareholder Return ("TSR") as measured on January 6, 2020 (the "2020 Measurement Date"). If Bausch Health's TSR for the period between the grant date and the 2020 Measurement Date is below the 50th percentile ranking of the TSR for the applicable peer group, the reporting person will receive no more than the number of Common Shares equal to the target number of performance-based RSUs subject to the award.
(5) Represents a grant of performance-based RSUs. The target number of performance-based RSUs granted to the reporting person was 4,546 and the maximum number that can be distributed is 9,092. The performance-based RSUs shall vest and be distributed between 0-200% of target based on TSR as measured for the 20 trading days preceding the TSR Measurement Date (the "2021 Measurement Date") which is the third anniversary of the grant date (March 7, 2021). If Bausch Health's TSR for the period between the grant date and the 2021 Measurement Date is below the 50th percentile ranking of the TSR for the applicable peer group based on the 20 trading days preceding the Measurement Date, the reporting person will receive no more than the number of Common Shares equal to the target number of performance-based RSUs subject to the award.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.